A STABLE PHARMACEUTICAL FORMULATION COMPRISING TORSEMIDE MODIFICATION II
摘要
Novel, stable pharmaceutical formulations for the oral administration of high purity torsemide modification II are disclosed. These formulations release high purity torsemide modification II in water at a constant and high purity rate, and the high purity torsemide modification II therein does not rearrange to torsemide modification I over time. Methods for their manufacture are also disclosed.
申请公布号
WO02067935(A1)
申请公布日期
2002.09.06
申请号
WO2001US05577
申请日期
2001.02.21
申请人
TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;LEIBOVICI, MINUTZA;TENENGAUZER, RUTH;KOPEL, MIRA;ARONHIME, JUDITH;KORDOVA, MARCO
发明人
LEIBOVICI, MINUTZA;TENENGAUZER, RUTH;KOPEL, MIRA;ARONHIME, JUDITH;KORDOVA, MARCO